Mikail Nima, Belew Daniel, Ullah Asad, Payne-Jamaeu Yolanda, Patel Nikhil, Kavuri Sravan, White Joseph, Madi Rabii
Department of Surgery, Section of Urology, Medical College of Georgia, Augusta University Health, Augusta, Georgia, USA.
Department of Pathology, Medical College of Georgia, Augusta University Health, Augusta, Georgia, USA.
J Endourol Case Rep. 2020 Dec 29;6(4):322-324. doi: 10.1089/cren.2020.0107. eCollection 2020.
Renal cell carcinoma (RCC) has a propensity to metastasize with the most common sites of metastasis being the lungs and bones. Cutaneous metastasis of RCC to the eyelid is exceedingly rare, with only six cases reported in the past decade. We are reporting a case of metastatic renal cell carcinoma (mRCC) that presented with a painless eyelid mass. We describe a case of a 66-year-old man with a history of chronic kidney disease stage III presenting with a rapidly growing left lower eyelid lesion thought to be a capillary hemangioma. Biopsy revealed polygonal clear cells with small central nuclei with thin-walled vasculature and strong immunostaining with PAX8 consistent with mRCC, clear cell type. Subsequent abdominal CT scan revealed a 5.1 × 4.7 × 4.3 cm heterogeneously enhancing mass with central necrosis in the upper pole of the left kidney. The patient was treated with excision of the eyelid lesion followed by robotic partial nephrectomy of the primary tumor. Follow-up CT scan at 3 and 6 months showed no evidence of recurrence. Isolated eyelid metastasis is an extremely rare form of presentation of mRCC. Interestingly, that patient did not have any other site of metastasis. Cytoreductive partial nephrectomy has been previously reported to be oncologically safe in selected patients.
肾细胞癌(RCC)易于发生转移,最常见的转移部位是肺和骨。RCC转移至眼睑的皮肤极为罕见,在过去十年中仅有6例报道。我们报告一例转移性肾细胞癌(mRCC),表现为无痛性眼睑肿物。我们描述了一例66岁男性患者,有慢性肾脏病III期病史,出现一个迅速增大的左下眼睑肿物,最初被认为是毛细血管瘤。活检显示多边形透明细胞,中央核小,有薄壁血管,PAX8免疫染色强,符合透明细胞型mRCC。随后的腹部CT扫描显示左肾上极有一个5.1×4.7×4.3 cm的不均匀强化肿物,中央坏死。患者接受了眼睑肿物切除,随后对原发肿瘤进行了机器人辅助部分肾切除术。3个月和6个月的随访CT扫描显示无复发迹象。孤立性眼睑转移是mRCC极为罕见的一种表现形式。有趣的是,该患者没有其他转移部位。此前报道过,在特定患者中,减瘤性部分肾切除术在肿瘤学上是安全的。